# Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

> **NCT03772314** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 44 (actual)

## Conditions studied

- Idiopathic Hypersomnia
- Narcolepsy Without Cataplexy

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Amphetamine-Dextroamphetamine

## Key facts

- **NCT ID:** NCT03772314
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2023-05-04
- **Final completion:** 2023-05-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03772314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03772314, "Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03772314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*